Robenacoxib

Robenacoxib
Clinical data
Trade names	Onsior
ATCvet code	QM01AH91 (WHO) ;
Legal status
Legal status	CA: ℞-only; US: ℞-only; EU: Rx-only;
Identifiers
	IUPAC name {5-Ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic acid;
CAS Number	220991-32-2;
PubChem CID	6433107;
DrugBank	DB11455;
ChemSpider	4938295;
UNII	Z588009C7C;
ChEBI	CHEBI:76269;
ChEMBL	ChEMBL2107774;
CompTox Dashboard (EPA)	DTXSID90176607 ;
ECHA InfoCard	100.210.035
Chemical and physical data
Formula	C16H13F4NO2
Molar mass	327.279 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O)Cc2c(Nc1c(F)c(F)cc(F)c1F)ccc(c2)CC;
	InChI InChI=1S/C16H13F4NO2/c1-2-8-3-4-12(9(5-8)6-13(22)23)21-16-14(19)10(17)7-11(18)15(16)20/h3-5,7,21H,2,6H2,1H3,(H,22,23); Key:ZEXGDYFACFXQPF-UHFFFAOYSA-N;

Robenacoxib, sold under the brand name Onsior, is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs.^[4]^[5] It is a COX-2 inhibitor (coxib).

^ "Onsior- robenacoxib injection". DailyMed. 19 November 2020. Retrieved 29 June 2024.
^ "Onsior- robenacoxib tablet". DailyMed. 9 November 2023. Retrieved 29 June 2024.
^ "Onsior EPAR". European Medicines Agency. 13 January 2010. Retrieved 29 June 2024.
^ Gaynor JS, Muir WM (2014). "Robenacoxib". Handbook of Veterinary Pain Management (3rd, revised ed.). Elsevier Health Sciences. ISBN 9780323222143.
^ Clark-Price S (2014). "Nonsteroidal anti-inflammatory drugs and corticosteroids: Robenacoxib". In Egger CM, Love L, Doherty T (eds.). Pain management in veterinary practice. Ames, Iowa: Wiley-Blackwell. ISBN 9781118761601.